Cargando…
Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141368/ https://www.ncbi.nlm.nih.gov/pubmed/25146474 http://dx.doi.org/10.2337/db13-1385 |
_version_ | 1782331640344739840 |
---|---|
author | Tian, Jide Dang, Hoa Nguyen, An Viet Chen, Zheying Kaufman, Daniel L. |
author_facet | Tian, Jide Dang, Hoa Nguyen, An Viet Chen, Zheying Kaufman, Daniel L. |
author_sort | Tian, Jide |
collection | PubMed |
description | Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic responses while ABT-induced regulatory responses arose and spread. γ-Aminobutyric acid (GABA) administration can inhibit inflammation, enhance regulatory T-cell (Treg) responses, and promote β-cell replication in mice. We examined the effect of combining a prototypic ABT, proinsulin/alum, with GABA treatment in newly diabetic NOD mice. Proinsulin/alum monotherapy failed to correct hyperglycemia, while GABA monotherapy restored normoglycemia for a short period. Combined treatment restored normoglycemia in the long term with apparent permanent remission in some mice. Proinsulin/alum monotherapy induced interleukin (IL)-4– and IL-10–secreting T-cell responses that spread to other β-cell autoantigens. GABA monotherapy induced moderate IL-10 (but not IL-4) responses to β-cell autoantigens. Combined treatment synergistically reduced spontaneous type 1 T-helper cell responses to autoantigens, ABT-induced IL-4 and humoral responses, and insulitis, but enhanced IL-10 and Treg responses and promoted β-cell replication in the islets. Thus, combining ABT with GABA can inhibit pathogenic T-cell responses, induce Treg responses, promote β-cell replication, and effectively restore normoglycemia in newly diabetic NOD mice. Since these treatments appear safe for humans, they hold promise for type 1 diabetes intervention. |
format | Online Article Text |
id | pubmed-4141368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-41413682015-09-01 Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice Tian, Jide Dang, Hoa Nguyen, An Viet Chen, Zheying Kaufman, Daniel L. Diabetes Pharmacology and Therapeutics Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic responses while ABT-induced regulatory responses arose and spread. γ-Aminobutyric acid (GABA) administration can inhibit inflammation, enhance regulatory T-cell (Treg) responses, and promote β-cell replication in mice. We examined the effect of combining a prototypic ABT, proinsulin/alum, with GABA treatment in newly diabetic NOD mice. Proinsulin/alum monotherapy failed to correct hyperglycemia, while GABA monotherapy restored normoglycemia for a short period. Combined treatment restored normoglycemia in the long term with apparent permanent remission in some mice. Proinsulin/alum monotherapy induced interleukin (IL)-4– and IL-10–secreting T-cell responses that spread to other β-cell autoantigens. GABA monotherapy induced moderate IL-10 (but not IL-4) responses to β-cell autoantigens. Combined treatment synergistically reduced spontaneous type 1 T-helper cell responses to autoantigens, ABT-induced IL-4 and humoral responses, and insulitis, but enhanced IL-10 and Treg responses and promoted β-cell replication in the islets. Thus, combining ABT with GABA can inhibit pathogenic T-cell responses, induce Treg responses, promote β-cell replication, and effectively restore normoglycemia in newly diabetic NOD mice. Since these treatments appear safe for humans, they hold promise for type 1 diabetes intervention. American Diabetes Association 2014-09 2014-08-16 /pmc/articles/PMC4141368/ /pubmed/25146474 http://dx.doi.org/10.2337/db13-1385 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. |
spellingShingle | Pharmacology and Therapeutics Tian, Jide Dang, Hoa Nguyen, An Viet Chen, Zheying Kaufman, Daniel L. Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice |
title | Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice |
title_full | Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice |
title_fullStr | Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice |
title_full_unstemmed | Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice |
title_short | Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice |
title_sort | combined therapy with gaba and proinsulin/alum acts synergistically to restore long-term normoglycemia by modulating t-cell autoimmunity and promoting β-cell replication in newly diabetic nod mice |
topic | Pharmacology and Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141368/ https://www.ncbi.nlm.nih.gov/pubmed/25146474 http://dx.doi.org/10.2337/db13-1385 |
work_keys_str_mv | AT tianjide combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice AT danghoa combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice AT nguyenanviet combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice AT chenzheying combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice AT kaufmandaniell combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice |